Nanobiotix S.A.
NBTX | NASDAQ
$34.40
-$0.10 (-0.29%)
Sep 22, 2026, 9:32 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 29.64M | -11.61M | 36.21M | 4.78M | 2.65M | 50K |
Cost of Revenue | n/a | n/a | n/a | 985K | n/a | n/a |
Gross Profit | 29.64M | -11.61M | 36.21M | 3.79M | 2.65M | 50K |
Operating Income | -10.82M | -68.39M | -26.78M | -46.7M | -52.58M | -36.43M |
Interest Income | 985K | 2.63M | 1.22M | 256K | 6.17M | n/a |
Pretax Income | -23.96M | -68.03M | -39.58M | -57.03M | -47M | -33.61M |
Net Income | -23.96M | -68.13M | -39.7M | -57.04M | -47M | -33.62M |
Selling & General & Admin | 20.22M | 20.06M | 22.05M | 17.48M | 19.43M | 14.27M |
Research & Development | 23.12M | 40.54M | 38.4M | 32.64M | 30.38M | 24.33M |
Other Expenses | -2.88M | -3.82M | 2.54M | 1.36M | 5.41M | 152K |
Operating Expenses | 40.46M | 56.78M | 62.99M | 51.48M | 55.23M | 38.75M |
Interest Expense | 10.4M | 8.09M | 7.98M | 5.84M | 671K | 333K |
Selling & Marketing Expenses | n/a | n/a | 388K | n/a | n/a | n/a |
Cost & Expenses | 40.46M | 56.78M | 62.99M | 51.48M | 55.23M | 36.53M |
Income Tax Expense | 3K | 101K | 120K | 10K | 5K | 9K |
Shares Outstanding (Basic) | 47.82M | 47.27M | 36.76M | 34.85M | 34.73M | 24.39M |
Shares Outstanding (Diluted) | 47.82M | 47.27M | 36.93M | 34.85M | 34.73M | 24.39M |
EPS (Basic) | -0.50 | -1.44 | -1.08 | -1.64 | -1.35 | -1.38 |
EPS (Diluted) | -0.50 | -1.44 | -1.08 | -1.64 | -1.35 | -1.38 |
EBITDA | -12.07M | -58.32M | -23.69M | -44.22M | -45.61M | -31.49M |
EBIT | -13.56M | -59.95M | -24.24M | -45.72M | -47.17M | -33.25M |
Depreciation & Amortization | 1.5M | 1.62M | 551K | 1.5M | 1.56M | 1.76M |
Add to Watchlist
Select watchlists to add or remove NBTX